AI brief
Science Corporation implanted its PRIMA vision-restoring chip in its first patient with Stargardt disease. Max Hodak, the company's founder and former Neuralink president, described the work as part of a path toward a novel brain-computer interface.
Why it matters: It marks a step in applying implantable hardware toward both vision restoration and future brain-computer interfaces.
Written by AI from TechCrunch AI's published text. Read the original for full details.